- Understand key elements of the FDA’s recent directives and their implications for increasing representation in clinical trials
- Review data on the growing emphasis on diversity in sponsor submissions and filings, and learn how to align strategies with industry trends
- Discover practical methods to recruit, engage, and retain underrepresented populations in clinical research
- Examine how prioritizing diversity improves study validity, compliance, and applicability, supported by real-world data
